Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials